Leap Therapeutics, Inc. (United States)
Home
Leap Therapeutics (Nasdaq: LPTX) is developing targeted therapy for cancer patients with DKK1expressing tumors. Leap’s DKN-01 targets the DKK1 protein.
Company details
- Address
- United States
- Website
- leaptx.com
Reviews
No reviews yet.
All reviews of Leap Therapeutics, Inc. (United States) · Write a review
Domain and WHOIS record
- Domain
- leaptx.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 15 Oct 2015
- Expires
- 15 Oct 2030
- Record updated
- 13 Sept 2026
- Name servers
- pdns13.domaincontrol.com, pdns14.domaincontrol.com
- DNSSEC
- Signed